Title : A therapeutic trial of human melanomas with combined small interfering RNAs targeting adaptor molecules p130Cas and paxillin activated under expression of ganglioside GD3.

Pub. Date : 2016 Aug

PMID : 27068854






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A therapeutic trial of human melanomas with combined small interfering RNAs targeting adaptor molecules p130Cas and paxillin activated under expression of ganglioside GD3. Gangliosides GRDX Homo sapiens
2 We previously demonstrated that focal adhesion kinase (FAK), p130Cas and paxillin are crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells. Gangliosides GRDX Homo sapiens